Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00204737 · ClinicalTrials.gov registry record · Phase 4
Short Course Glucocorticoid Treatment for PTSD
A Phase 4 study of Post Traumatic Stress Disorder, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 4
- Development phase
- 12
- Enrollment target
- 2
- Study locations
NCT00204737 is a Phase 4 study of Post Traumatic Stress Disorder that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 12 participants, below the 1,117-participant average among 144 other Post Traumatic Stress Disorder trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT00204737, a Phase 4 study of Post Traumatic Stress Disorder, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 12 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to investigate if a 2-wk course of 20mg/day of oral prednisone in addition to standard care will result in reduced PTSD symptoms or symptom severity compared to placebo
Conditions Studied
Interventions
- DRUG placebo
- DRUG prednisone
Study Locations (2)
Wisconsin
- Catherine Johnson - Madison
- Wm. S. Middleton VA Hospital - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2004-12 |
| Est. Completion | 2009-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00204737
The ClinicalTrials.gov registry entry for NCT00204737 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,117-participant average among 144 other Post Traumatic Stress Disorder trials with a reported enrollment target (99% lower). The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.
NCT00204737 reports 2 study locations spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT00204737 about?
NCT00204737 is a clinical study titled "Short Course Glucocorticoid Treatment for PTSD". The purpose of this study is to investigate if a 2-wk course of 20mg/day of oral prednisone in addition to standard care will result in reduced PTSD symptoms or symptom severity compared to placebo
What is the current status of trial NCT00204737?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 12 participants. The study started on 2004-12. Estimated completion is 2009-01.
What conditions does trial NCT00204737 study?
This clinical trial studies the following conditions: Post Traumatic Stress Disorder.
What interventions are being tested in trial NCT00204737?
The interventions under investigation include: placebo (DRUG), prednisone (DRUG).
Who is sponsoring clinical trial NCT00204737?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00204737 being conducted?
This trial has 2 study locations across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post Traumatic Stress Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effects of Stellate Ganglion Block in Post-traumatic Stress Disorder
RECRUITING · Phase 4
-
An Open Label Pilot Study of IV Brexanolone for the Treatment of Post-Traumatic Stress Disorder
RECRUITING · Phase 4
-
Preventing Post-Operative Delirium in Patients Undergoing a Pneumonectomy, Esophagectomy or Thoracotomy
COMPLETED · Phase 4
-
Effect of Propranolol on Preventing Posttraumatic Stress Disorder
COMPLETED · Phase 4
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Department of Defense PTSD Adaptive Platform Trial - Intervention A - Fluoxetine
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.